Recombitek Lyme (rLyme) provides unsurpassed efficacy without the potentially harmful flagellan protein. Plus, Recombitek Lyme contains no chemical adjuvants, thus eliminating the potential risk typically associated with adjuvants.
Key Benefits:
- Effective protection that blocks Borrelia burgdorferi while it’s still in the tick
- THE ONLY canine Lyme vaccine that is non-adjuvanted
- THE ONLY recombinant Lyme vaccine that contains lipidated OspA
- Proven 1-year immunity and a robust, homogeneous, and high avidity immune response.
